New therapy could beat CBT for anxiety – but is it too early to tell?

NCT ID NCT06937892

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a newer type of talk therapy called transdiagnostic metacognitive therapy (tMCT) works better than standard cognitive-behavioral therapy (CBT) for people with generalized anxiety, social anxiety, or PTSD. About 86 adults in Sweden will receive either tMCT or CBT, and their symptoms will be tracked for a year. The goal is to see if tMCT leads to greater improvement and is more cost-effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transdiagnostic metacognitive therapy (tMCT) and disorder-specific cognitive-behavioral therapy (CBT)
What this could lead to
If tMCT proves superior, it could offer a simpler, more effective treatment for multiple anxiety disorders, potentially improving remission rates and reducing dropout.
What could go wrong
This is a relatively small trial (86 participants) comparing two active therapies, so any advantage may be modest or not generalizable. Both treatments require skilled therapists, and results depend on long-term follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENERALIZED ANXIETY DISORDER (GAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Stockholm North Psychiatry Clinic

    RECRUITING

    Stockholm, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.